Rewalk Robotics (NASDAQ:RWLK) Posts Earnings Results, Beats Expectations By $0.04 EPS

Rewalk Robotics (NASDAQ:RWLK) released its quarterly earnings data on Friday, February 8th. The medical device company reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.04, Morningstar.com reports. The company had revenue of $1.58 million during the quarter. Rewalk Robotics had a negative net margin of 331.18% and a negative return on equity of 3,654.32%.

Shares of RWLK traded up $0.01 during mid-day trading on Friday, hitting $0.26. The company’s stock had a trading volume of 4,520,001 shares, compared to its average volume of 9,231,593. Rewalk Robotics has a 52-week low of $0.16 and a 52-week high of $1.35. The stock has a market capitalization of $19.40 million, a PE ratio of -0.44 and a beta of 1.88. The company has a debt-to-equity ratio of 3.59, a quick ratio of 2.04 and a current ratio of 2.46.

Separately, ValuEngine cut shares of Rewalk Robotics from a “hold” rating to a “sell” rating in a research report on Friday, December 7th. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company’s stock. Rewalk Robotics presently has an average rating of “Hold” and a consensus price target of $1.56.

A hedge fund recently bought a new stake in Rewalk Robotics stock. Geode Capital Management LLC purchased a new position in Rewalk Robotics Ltd (NASDAQ:RWLK) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 284,311 shares of the medical device company’s stock, valued at approximately $49,000. Geode Capital Management LLC owned 0.79% of Rewalk Robotics as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 2.78% of the company’s stock.

WARNING: This article was originally reported by Fairfield Current and is the property of of Fairfield Current. If you are viewing this article on another site, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The legal version of this article can be read at https://www.fairfieldcurrent.com/news/2019/03/03/rewalk-robotics-rwlk-releases-quarterly-earnings-results-beats-estimates-by-0-04-eps.html.

About Rewalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.

Featured Story: Gap Down Stocks

Receive News & Ratings for Rewalk Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Rewalk Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.